Vice President
Certara
Vice President
Certara
Biosimulation and model-informed drug development platform
About Certara
Certara accelerates the potential of bringing medicines to market and to patients using biosimulation software, technology, and services to transform traditional drug discovery and development. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.
As we continue to evolve our scientific capabilities and technology platforms, we are seeking a Vice President of Translational Science (DMPK) to provide scientific leadership, strategic vision, and innovation across Simcyp’s Translational Science team.
The Vice President of Translational Science (Drug Metabolism and Pharmacokinetics, DMPK) leads Simcyp’s Translational Science organisation, shaping the scientific direction of DMPK‑driven Physiologically Based Pharmacokinetic (PBPK) innovation while partnering closely with clients, key opinion leaders, regulators, and cross‑functional internal teams.
This role combines scientific excellence, executive leadership, strategic decision‑making, and external influence, with a strong focus on delivering high‑impact Model‑Informed Drug Development (MIDD) through the Simcyp platform.
You will champion innovative translational approaches, including the application of AI/ML and advanced data science, to enhance data integration, model translation, predictive performance, and platform evolution.
Scientific & Strategic Leadership
Platform & Technical Oversight
Stakeholder Engagement
People & Organizational Leadership
Executive Leadership
Certara bases all employment-related decision on merit, taking into consideration qualifications, skills, achievement, and performance. We treat all applicants and employees without regard to personal characteristics such as race, color, ethnicity, religion, sex, sexual orientation, age, nationality, marital status, pregnancy, physical or mental condition, genetic information, military service, or other characteristic protected by law.
Certara provides biosimulation and model-informed drug development tools and services to biopharma, CROs, and researchers. Its platforms include Phoenix WinNonlin for PK/PD and non-compartmental analysis, Simcyp for PBPK modeling, and D360 for scientific informatics, plus Certara.AI for AI-assisted medical writing and regulatory documentation, enabling users to build and run mathematical models that predict drug behavior across development. It differentiates itself with an end-to-end ecosystem, deep regulatory experience, and wide adoption among leading companies and agencies. Its goal is to speed up decision-making, reduce uncertainty, and help deliver safe, effective medicines to patients faster.
Explore more opportunities at Certara